Also, TRPV2 overexpression confers a drug-resistant phenotype in gastric cancer, suggesting that promoting tumor cell apoptosis by targeting TRPV2 may be a potential treatment for overcoming drug resistance [30]. The gene discussed is TRPV2; the disease is neoplasm.